Advertisement

Impaired Sexual Function

  • Cheryl Waters
  • Janice Smolowitz
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

The incidence of impaired sexual function in adults with Parkinson’s disease (PD) is greater than in the general population. Studies have examined different aspects of sexual function among adults with PD and their partners. Comparison groups have included healthy adults matched for age and gender, as well as age-matched controls with chronic, non-neurological disease with motor impairment. Impaired sexual function in PD is most likely multifactorial. Depression, physical disability, and autonomic dysfunction may contribute to the increased prevalence of erectile dysfunction (ED) in PD. Given this multifactorial basis, clinicians should routinely assess patient needs. In studies of men with PD, treatment with sildenafil significantly improved sexual satisfaction. Also, erection has been reported as a side effect of subcutaneous apomorphine treatment of resistant motor fluctuations. As a treatment for ED, sublingual apomorphine is available in Europe. For women with PD, therapeutic interventions and impaired sexual function have not been described. Further research is required to develop treatment for adults with PD and sexual dysfunction.

Key Words

Erectile dysfunction hyposexuality sexual dysfunction reduced libido sexual dissatisfaction decreased sexual activity impaired sexual function 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Allen ME. A holistic view of sexuality and the aged. Holist Nurs Pract 1987;1:76–83.PubMedGoogle Scholar
  2. 2.
    Woods NF. Toward a holistic perspective of human sexuality: alterations in sexual health and nursing diagnoses. Holist Nurs Pract 1987;1:1–11.PubMedGoogle Scholar
  3. 3.
    Johnson BK. Older adults and sexuality: A multidimensional perspective. J Gerontol Nurs 1996;22: 6–15.PubMedGoogle Scholar
  4. 4.
    Singer C, Weiner WJ. Erectile and ejaculatory disturbance: overview of diagnosis and treatment. In: Sexual Dysfunction: a Neuromedical Approach, Futura, Armonk, NY, 1994, pp. 45–59.Google Scholar
  5. 5.
    Berman JR, Berman L, Goldstein I. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology 1999;54:385–391.PubMedCrossRefGoogle Scholar
  6. 6.
    Woods NF. Human Sexuality in Health and Illness, 2nd ed. C.V. Mosby, St. Louis, MO, 1972.Google Scholar
  7. 7.
    Shabsigh R, Anastasiadis AG. Erectile dysfunction. Annu Rev Med 2003;54:153–168.PubMedCrossRefGoogle Scholar
  8. 8.
    Burguera JA, Garcia Reboll L, Martinez Agullo E. Sexual dysfunction in Parkinson’s disease. Neurologia. 1994;9:178–181.PubMedGoogle Scholar
  9. 9.
    Jacobs H, Vieregge A, Vieregge P. Sexuality in young patients with Parkinson’s disease: a population based comparison with healthy controls. J Neurol Neurosurg Psychiatry 2000;69:550–552.PubMedCrossRefGoogle Scholar
  10. 10.
    Wermuth L, Stenager E. Sexual problems in young patients with Parkinson’s disease. Acta Neurol Scand 1995;91:453–455.PubMedCrossRefGoogle Scholar
  11. 11.
    Koller WC, Vetere-Overfeld B, Williamson A, et al. Sexual dysfunction in Parkinson’s disease. Clinical Neuropharmacol 1990;13:461–463.CrossRefGoogle Scholar
  12. 12.
    Brown RG, Jahanshahi M, Quinn N, Marsden CD. Sexual function in patients with Parkinson’s disease and their partners. J Neurol Neurosurg Psychiatry 1990;53:480–486.PubMedGoogle Scholar
  13. 13.
    Singer C, Weiner WJ, Sanchez-Ramos J, Ackerman M. Sexual function in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1991;54:942.PubMedGoogle Scholar
  14. 14.
    Singer C, Weiner WJ, Sanchez-Ramos J. Autonomic dysfunction in men with Parkinson’s disease. Eur Neurol 1992;32:134–140.PubMedGoogle Scholar
  15. 15.
    Lipe H, Longstreth WT. Jr., Bird T. D, Linde M. Sexual function in married men with Parkinson’s disease compared to married men with arthritis. Neurology 1990;40:1347–1349.PubMedGoogle Scholar
  16. 16.
    Welsh M, Hung L, Waters CH. Sexuality in women with Parkinson’s disease. Mov Disord 1997; 12:923–927.PubMedCrossRefGoogle Scholar
  17. 17.
    Lambert D, Waters C. Sexual dysfunction in Parkinson’s disease. Clin Neurosci 1998;5: 73–77.PubMedCrossRefGoogle Scholar
  18. 18.
    Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537–544.PubMedCrossRefGoogle Scholar
  19. 19.
    Jonler M, Moon T, Brannan W, et al. The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol 1995;75:651–655.PubMedGoogle Scholar
  20. 20.
    NIH Consensus Development Panel on Impotence. NIH Consensus Conference: Impotence. JAMA 1992;270: 83–90.Google Scholar
  21. 21.
    Johannes CB, Araujo AB, Feldman HA, et al. Incidence of erectile dysfunction in men 40–69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000;163:460–463.PubMedCrossRefGoogle Scholar
  22. 22.
    Blanker MH, Bohnen AM, Groeneveld FP, et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community based study. J Am Geriatr Soc. 2001;49:436–442.PubMedCrossRefGoogle Scholar
  23. 23.
    Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 2001; 166:569–575.PubMedCrossRefGoogle Scholar
  24. 24.
    Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the “Cologne Male Survey.” Int J Impot Res 2000;12:305–311.PubMedCrossRefGoogle Scholar
  25. 25.
    Chew KK, Earle CM, Stuckey BG, et al. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res 2000;12:41–45.PubMedCrossRefGoogle Scholar
  26. 26.
    Masters W, Johnson V. Human Sexual Response. Little Brown and Company, Boston, MA, 1966.Google Scholar
  27. 27.
    Kaplan HS. The New Sex Therapy. Brunner/Mazel Inc., New York, 1974.Google Scholar
  28. 28.
    Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 1990;19:389–408.PubMedCrossRefGoogle Scholar
  29. 29.
    Rosen RC, Taylor JF, Leiblum SR, Bachmann GA. Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther 1993;19:171–188.PubMedGoogle Scholar
  30. 30.
    Read S, King M, Watson J. Sexual dysfunction in primary medical care: prevalence, characteristics, and detection by the general practitioner. J Public Health Med 1997;19:387–391.PubMedGoogle Scholar
  31. 31.
    Fahn S, Elton RI, Members of the UPDRS Development Committee. Unified Parkinson’s disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, eds. Recent Developments in Parkinson’s Disease II. Macmillan, Florham Park, 1987, pp. 153–163.Google Scholar
  32. 32.
    Hoehn M, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–442.PubMedCrossRefGoogle Scholar
  33. 33.
    Schneider HD. Sexualverhalten in der zweiten Lebenshalfte: Ergebnisse sozialwissenschaftlicher Forschung. Kohl-hammer Verlag, Stuttgart, 1980.Google Scholar
  34. 34.
    Zerssen D Von, Koeller DM. Paranoid-Depressivitats-Skala. Beltz Test, Weinheim, 1976.Google Scholar
  35. 35.
    Wechsler D. Handanweisung zum Hamburg-Weschler-Intelligenztest fur Erwachsene (HAWIE). Hans Huber Verlag, Bern, 1982.Google Scholar
  36. 36.
    Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 1974;7:151–169.PubMedGoogle Scholar
  37. 37.
    Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatric Res 1982–1983;17:37–49.CrossRefGoogle Scholar
  38. 38.
    Othmer E, Othmer SC. Evaluation of sexual dysfunction. J Clin Psychiatry 1987;48:191–193.PubMedGoogle Scholar
  39. 39.
    Rust J, Golombok S. The Golombok Rust Inventory of Sexual Satisfaction. NFER-Nelson, Windsor, 1986.Google Scholar
  40. 40.
    Rust J, Bennun I, Crowe M, Golombok S. The Golombok-Rust inventory of marital state. Sex Marital Ther 1988;1:55–60.Google Scholar
  41. 41.
    Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA, 1970.Google Scholar
  42. 42.
    Felton BJ, Revenson TA. Coping with chronic illness: a study of illness controllability and the influence of coping strategies on psychological adjustment. J Consult Clin Psychol. 1984;52:343–353.PubMedCrossRefGoogle Scholar
  43. 43.
    Robinson BC. Validation of a Caregiver Strain Index. J Gerontol 1983;38:344–348.PubMedGoogle Scholar
  44. 44.
    Yahr MD, Duvoisin RC, Schear MJ, et al. Treatment of Parkinsonism with levodopa. Arch Neurol 1969; 21:343–354.PubMedGoogle Scholar
  45. 45.
    Steinbrocker O, Traeyer CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140:659–662.Google Scholar
  46. 46.
    Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63–70.PubMedGoogle Scholar
  47. 47.
    Watts RJ. Sexual functioning, health beliefs, and compliance with high blood pressure medications. Nurs Res 1982;31:278–283.PubMedCrossRefGoogle Scholar
  48. 48.
    Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arch Sex Behav 1994;23:627–643.PubMedCrossRefGoogle Scholar
  49. 49.
    Giuliano FA, Rampin O, Benoit G, Jardin A. Neural control of penile erection. Urol Clin North Am 1995;22:747–766.PubMedGoogle Scholar
  50. 50.
    Burnett AL. Neurophysiology of erectile function and dysfunction. In: Hellstrom WJG, ed. The Handbook of Sexual Dysfunction. The American Society of Andrology, San Francisco, CA, 1999, pp. 12–17.Google Scholar
  51. 51.
    Saenz de Tejada I. Anatomy physiology, and pathophysiology of erectile dysfunction. In: Jardin A, Wagner G, Khoury S, eds. Erectile Dysfunction. Plymbridge Distrib., Plymouth, UK, 2000, pp. 65–102.Google Scholar
  52. 52.
    Goldstein I. Male sexual circuitry. Working Group for the Study of Central Mechanisms in Erectile Dysfunction. Sci Am 2000;283:70–75.PubMedCrossRefGoogle Scholar
  53. 53.
    McCarty T, Fromm L, Weiss-Roberts L, et al. In: Copeland L, ed. Textbook of Gynecology. Saunders, Philadelphia, PA, 2000, pp. 475–485.Google Scholar
  54. 54.
    Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990;75(4 Suppl):26S–30S.PubMedGoogle Scholar
  55. 55.
    O’Sullivan JD, Hughes AJ. Apomorphine-induced penile erections in Parkinson’s disease. Mov Disord 1998;13:536–539.PubMedCrossRefGoogle Scholar
  56. 56.
    World Health Organization. Education and treatment in human sexuality: the training of health professionals. Report of the WHO Meeting. Technical Report Services, 1975, no. 572.Google Scholar
  57. 57.
    Jardin A, Wagner G, Khoury S, et al. Recommendations of the first international consultation on erectile dysfunction. In: Jardin A, Wagner G, Khoury S, et al. eds. Erectile Dysfunction. Plymbridge Dist., Plymouth, UK, 2000, pp. 711–726.Google Scholar
  58. 58.
    Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clinical Pharmacol 1999;19:67–85.Google Scholar
  59. 59.
    Okun MS, McDonald WM, DeLong MR. Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity. Arch Neurol 2002;59:807–811.PubMedCrossRefGoogle Scholar
  60. 60.
    Zesiewicz TA, Helal M, Hauser RA. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson’s disease. Mov Disord 2000;15:305–308.PubMedCrossRefGoogle Scholar
  61. 61.
    Hussain IF, Brady CM, Swinn MJ, et al. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in Parkinsonism due to Parkinson’s disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001;71:371–374.PubMedCrossRefGoogle Scholar
  62. 62.
    Cohan P, Korenman SG. Erectile dysfunction. J Clin Endocrinol Metab 2001;86:2391–2394.PubMedCrossRefGoogle Scholar
  63. 63.
    Carani C, Scuteri A, Marrama P, Bancroft J. The effects of testosterone administration and visual erotic stimuli on nocturnal penile tumescence in normal men. Horm Behav 1990;24:435–441.PubMedCrossRefGoogle Scholar
  64. 64.
    Bhasin S. The dose-dependent effects of testosterone on sexual function and on muscle mass and function. Mayo Clin Proc 2000;75(Suppl):S75–S76.Google Scholar
  65. 65.
    Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49:1239–1242.PubMedCrossRefGoogle Scholar
  66. 66.
    Padma-Nathan H, Giuliano F. Oral drug therapy for erectile dysfunction. Urol Clin North Am 2001;28: 321–334.PubMedCrossRefGoogle Scholar
  67. 67.
    Wespes E, Amar E, Hatzichristou D, et al. Guidelines on erectile dysfunction. Eur Urol 2002;41: 1–5.PubMedCrossRefGoogle Scholar
  68. 68.
    Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged 5-item version of the International Index of Erectile Dysfunction (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319–326.PubMedCrossRefGoogle Scholar
  69. 69.
    Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49: 822–830.PubMedCrossRefGoogle Scholar
  70. 70.
    Steiger MJ, Quinn NP, Marsden CD. The clinical use of apomorphine in Parkinson’s disease. J Neurol 1992;239:389–393.PubMedGoogle Scholar
  71. 71.
    Gower AJ, Berendsen HG, Princen MM, Broekkamp CLE. The yawning-penile erection syndrome as a putative model for dopamine autoreceptor activity. Eur J Pharmacol 1984;103:81–89.PubMedCrossRefGoogle Scholar
  72. 72.
    Lal S, Laryea E, Thavundayil JX, et al. Apomorphine induced penile tumescence in impotent patients-preliminary findings. Prog Neuropsychopharmacol Biol Psychiatry 1987;11:235–242.PubMedCrossRefGoogle Scholar
  73. 73.
    Nair NP, Lal S, Iskandar HI, et al. Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion. Brain Res Bull 1982;8:587–591.PubMedCrossRefGoogle Scholar
  74. 74.
    Lal S, Nair NP, Iskandar HL, et al. Effect of domperidone on apomorphine-induced growth hormone secretion in normal men. J Neural Transm 1982;54:75–84.PubMedCrossRefGoogle Scholar
  75. 75.
    Argiolas A, Melis MR, Mauri A, Gessa GL. Paraventricular nucleus lesion prevents yawning and penile erection induced by apomorphine and oxytocin but not ACTH in rats. Brain Res 1987;421:349–352.PubMedCrossRefGoogle Scholar
  76. 76.
    Heaton JP, Morales A, Adams MA, et al. Recovery of erectile function by the oral administration of apomorphine. Urology 1995;45:200–206.PubMedCrossRefGoogle Scholar
  77. 77.
    Burnett AL. Oral pharmacotherapy for erectile dysfunction: current perspectives. Urology 1999;54: 392–400.PubMedCrossRefGoogle Scholar
  78. 78.
    Horita H, Sato Y, Adachi H, et al. Effects of levodopa on nocturnal penile tumescence: a preliminary study. J Androl 1998;19:619–634.PubMedGoogle Scholar
  79. 79.
    Sandyk R. AC pulsed electromagnetic fields-induced sexual arousal and penile erections in Parkinson’s disease. Int J Neurosci 1999;99:139–149.PubMedGoogle Scholar
  80. 80.
    Uitti R. J, Tanner C. M, Rajput A. H, et al. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989;12:375–383.PubMedCrossRefGoogle Scholar
  81. 81.
    Weinman E, Ruskin PE. Levodopa dependence and hypersexuality in older Parkinson disease patients. Am J Geriatr Psychiatry 1995;3:81–83.Google Scholar
  82. 82.
    Basson R, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000;163:888–893.PubMedCrossRefGoogle Scholar
  83. 83.
    American Psychiatric Association: DSM-IV Diagnostic and statistical manual of mental disorders, edition 4. American Psychiatric Press, Washington, DC, 1994.Google Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2005

Authors and Affiliations

  • Cheryl Waters
    • 1
  • Janice Smolowitz
    • 2
  1. 1.Department of NeurologyColumbia UniversityNew York
  2. 2.Department of Clinical NursingColumbia UniversityNew York

Personalised recommendations